{"url":"https://newsforagent.com/news/2026-11-02/innovassynth-joshipura-reappointment-md-ceo","markdown_url":"https://newsforagent.com/news/2026-11-02/innovassynth-joshipura-reappointment-md-ceo.md","title":"Innovassynth Reappoints Dr. Hardik Joshipura as MD and CEO","headline":"Innovassynth Board Reappoints Dr. Hardik Joshipura as MD and CEO for Three Years","description":"Innovassynth's board approved Dr. Hardik Joshipura's reappointment as MD and CEO for a three-year term from February 12, 2027.","section":"Leadership","published_at":"2026-11-02T15:52:47+00:00","modified_at":"2026-11-02T15:52:47+00:00","author":"News Desk","key_takeaways":["Innovassynth's board approved Dr. Hardik Joshipura's reappointment as Managing Director and CEO on November 2, 2026.","The new three-year term runs from February 12, 2027 to February 11, 2030 and is subject to shareholder approval.","Dr. Joshipura holds a Ph.D. in Organic Chemistry and an Executive MBA from Harvard Business School."],"companies":[{"name":"Innovassynth","is_primary":true,"profile_url":"https://akta.pro/company-profiles/000kxey/innovassynth","website":"https://www.innovassynth.com"}],"source":{"publisher":"ScanX","title":"Innovassynth Technologies re-appoints Dr. Hardik Joshipura as MD & CEO","url":"https://scanx.trade/stock-market-news/companies/innovassynth-technologies-re-appoints-dr-hardik-joshipura-md-ceo/55178424"},"other_sources":[],"tags":["Leadership","Innovassynth"],"body_markdown":"Innovassynth Technologies (India) Limited's board approved the reappointment of Dr. Hardik Joshipura as Managing Director and CEO for a further three-year term, from February 12, 2027 to February 11, 2030, subject to shareholder approval. [ScanX](https://scanx.trade/stock-market-news/companies/innovassynth-technologies-re-appoints-dr-hardik-joshipura-md-ceo/55178424) reported the decision, taken at a board meeting on November 2, 2026.\n\n## Innovassynth Board Vote and Term Details\n\nThe board acted on the recommendation of its Nomination and Remuneration Committee, and the filing went to BSE Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The reappointment follows the completion of Dr. Joshipura's existing term. The company said he is not related to any other directors or key managerial personnel and is not debarred from holding office by any regulatory authority. The company also noted that Dr. Joshipura shall be liable to retire by rotation during his tenure.\n\nDr. Joshipura's background includes manufacturing, sales and global strategic marketing experience. Before joining [Innovassynth](https://akta.pro/company-profiles/000kxey/innovassynth), he held senior leadership roles at Sigma-Aldrich and Merck KGaA, and his career began at Zydis Cadila, where he led Contract Research R&D for the Fine Chemicals business. He holds a Ph.D. in Organic Chemistry and an Executive MBA from Harvard Business School in Boston.\n\n## Innovassynth's Rights Issue and Quarterly Results\n\nAccording to akta.pro [company records](https://akta.pro/company-data), Innovassynth announced a Rs 69.65 crore rights issue scheduled for April 2026, with a record date of April 28-29, 2026, to raise capital from existing shareholders. The same records show Q3 FY2025-26 standalone sales of Rs 21.97 crore, a 55.98% year-on-year decline, and a swing to a Rs 7.80 crore net loss from a Rs 9.19 crore profit in the prior-year quarter. The records list a workforce of 600 or more, including scientists and technicians, and manufacturing infrastructure of more than 60 acres with a production plant in Khopoli and headquarters in Pune.\n\n## Innovassynth Shareholder Vote at the 18th AGM\n\nAt the 18th Annual General Meeting held on September 30, 2026, shareholders approved the re-appointment of Dr. Joshipura as a director retiring by rotation, with 69,849,955 votes in favour and 336 against, or 99.9995% in favour, according to ScanX. The results were declared by Sameer Salim Pakhali, Company Secretary and Compliance Officer, on October 1, 2026.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}